SOURCE: SolarBrook Water and Power Corporation

December 29, 2009 07:00 ET

Solarbrook Discusses Purchase of Endocrine Removal Technology

CARY, NC--(Marketwire - December 29, 2009) - On November 17, 2009, Solarbrook Water and Power Corporation (PINKSHEETS: SLRW) bought the provisional patent application with the U.S. Patent and Trademark Office for hormone removal in water. The process uses an efficient ozone process for eliminating EDCs (Endocrine Disrupting Chemicals), as well as waterborne hormones and other compounds of emerging concern. The attached chart lists certified lab results on the removal of hormone and drugs in drinking water.

The unintended human ingestion of hormones in drinking water has been implicated in early onset of puberty, reproductive diseases in women, and deterioration in human male fertility. Studies on EDC effects on human physiology are intense and ongoing. In the United States many laws include EDCs and hormones, such as the Food, Drug and Cosmetic Act, the Federal Insecticide, Fungicide, and Rodenticide Act, the Clean Water Act, the Safe Drinking Water Act, the Clean Air Act, and the Toxic Substances Control Act.

     Chemical                Description             Percent reduction
                             After treatment

     Codeine                 Opiate                        100%
     Caffeine                Stimulant                      40%
     Acetaminophen           Pain reliever                  93%
     Sulfamethoxazole        Antibiotic                    100%
     Fluoxetine              Antibiotic                     37%
     Albuterol               Bronchodialator                99%
     Cimctidine              Ulcer treatment                97%
     Progesterone            Estrogen Therapy               48%
     Testosterone            Estrogen Therapy               47%
     Estrone                 Estrogen Therapy               32%
     Estradiol               Estrogen Therapy               35%
     Menstranol              Estrogen Therapy               14%
     Ibuproprofen            NSAID                          25%
     Naproxen                NSAID                         100%
     Warfarin                Anti-Coagulant                 98%

CEO of Solarbrook George Moore said, "The addition of this new technology has enabled CWSI to develop a system for whole house treatment. We see it as a new and exciting advance in providing drug free pure drinking water to the individual home owner at a reasonable cost. In future presses we will discuss the advanced home water treatment system and our future marketing plans."

About Solarbrook Water and Power Corporation

Solarbrook Water and Power Corporation, headquartered in Cary, North Carolina, maintains a core focus of seeking out synergistic acquisitions that will provide capital appreciation and income for its companies. The mission of Solarbrook is to acquire and develop innovative green technologies and businesses that will improve the quality of water, and provide green options to energy throughout the world. We work to achieve these goals by means of detection, treatment and removal of contaminants, and to provide integrated clean power alternatives for remote and off-grid systems, further expanding market potential.

For more information, please visit

Forward-Looking Statements

Statements regarding financial matters in this press release other than historical facts are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. The company intends that such statements about the Company's future expectations, including future revenues and earnings, and all other forward-looking statements be subject to the safe harbors created thereby. Since these statements (future operational results and sales) involve risks and uncertainties and are subject to change at any time, the Company's actual results may differ materially from expected results.

Contact Information

  • Contact:
    George Moore
    PO Box 1863
    Cary, NC 27512